Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019Masahito Nakano, Takuji Torimura, Masaru Harada et al.|Scientific Reports|2022Cited by 43
Comparison of Efficacy and Safety of Atezolizumab Plus Bevacizumab and Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching AnalysisTakashi Niizeki, Yasuhito Tanaka, Takayuki Tokunaga et al.|Targeted Oncology|2022Cited by 41
The Result of SELENE (KAGUYA) Development and Operation~!2009-06-28~!2009-08-10~!2009-10-01~!Shinichi Sobue, Akira Mukaida, Susumu Sasaki et al.|Recent Patents on Space Technology|2009Cited by 8
Trends in Hepatocellular Carcinoma Incidences in Japan Between 1996 and 2019Masahito Nakano, Takuji Torimura, Hiroshi Yatsuhashi et al.|Research Square|2021Cited by 1